Inhibrx Biosciences, Inc. Quarterly Nonoperating Income (Expense) in USD from Q2 2023 to Q3 2024

Taxonomy & unit
us-gaap: USD
Description
The aggregate amount of income or expense from ancillary business-related activities (that is to say, excluding major activities considered part of the normal operations of the business).
Summary
Inhibrx Biosciences, Inc. quarterly Nonoperating Income (Expense) history and growth rate from Q2 2023 to Q3 2024.
  • Inhibrx Biosciences, Inc. Nonoperating Income (Expense) for the quarter ending September 30, 2024 was $2.93M.
Nonoperating Income (Expense), Quarterly (USD)
* An asterisk sign (*) next to the value indicates that the value is likely invalid.